Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Chronic hepatitis B infection: a review
LSY Tang, E Covert, E Wilson, S Kottilil - Jama, 2018 - jamanetwork.com
Importance More than 240 million individuals worldwide are infected with chronic hepatitis B
virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40 …
virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40 …
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
Background & Aims The risk of hepatocellular carcinoma (HCC) during antiviral therapy in
patients with chronic hepatitis B (CHB) is inadequately predicted by the scores built from …
patients with chronic hepatitis B (CHB) is inadequately predicted by the scores built from …
[HTML][HTML] HBsAg loss with peg-interferon alfa-2a in hepatitis B patients with partial response to nucleos (t) ide analog: new switch study
P Hu, J Shang, W Zhang, G Gong, Y Li… - Journal of clinical and …, 2018 - ncbi.nlm.nih.gov
Abstract Background and Aims: Hepatitis B surface antigen (HBsAg) loss is seldom
achieved with nucleos (t) ide analog (NA) therapy in chronic hepatitis B patients but may be …
achieved with nucleos (t) ide analog (NA) therapy in chronic hepatitis B patients but may be …
Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis
T García‐Lezana, I Raurell, M Bravo… - Hepatology, 2018 - journals.lww.com
Portal hypertension (PH) drives most of the clinical complications in chronic liver diseases.
However, its progression in nonalcoholic steatohepatitis (NASH) and its association with the …
However, its progression in nonalcoholic steatohepatitis (NASH) and its association with the …
Management of hepatitis B virus infection: 2018 guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and …
Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …
No resistance to tenofovir alafenamide detected through 96 weeks of treatment in patients with chronic hepatitis B infection
AL Cathcart, HLY Chan, N Bhardwaj, Y Liu… - Antimicrobial Agents …, 2018 - Am Soc Microbiol
Tenofovir alafenamide (TAF) has shown equivalent efficacy and improved safety profiles for
patients with chronic hepatitis B (CHB) compared to tenofovir disoproxil fumarate (TDF) …
patients with chronic hepatitis B (CHB) compared to tenofovir disoproxil fumarate (TDF) …
Medication nonadherence increases hepatocellular carcinoma, cirrhotic complications, and mortality in chronic hepatitis B patients treated with entecavir
JW Shin, SW Jung, SB Lee, BU Lee… - Official journal of the …, 2018 - journals.lww.com
OBJECTIVES: Optimal adherence to nucleoside analogue treatment is necessary to achieve
undetectable levels of hepatitis B virus (HBV) DNA in patients with chronic hepatitis B (CHB) …
undetectable levels of hepatitis B virus (HBV) DNA in patients with chronic hepatitis B (CHB) …
Systematic review with meta‐analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen …
K Qiu, B Liu, SY Li, H Li, ZW Chen… - Alimentary …, 2018 - Wiley Online Library
Background The seroclearance of hepatitis B surface antigen (HB sAg) in patients with
chronic hepatitis B (CHB) is considered to be associated with favourable clinical outcomes …
chronic hepatitis B (CHB) is considered to be associated with favourable clinical outcomes …
Randomized prospective study showing the non‐inferiority of tenofovir to entecavir in treatment‐naïve chronic hepatitis B patients
K Koike, K Suyama, H Ito, H Itoh… - Hepatology …, 2018 - Wiley Online Library
Aim The study aimed to evaluate the efficacy and safety of tenofovir disoproxil fumarate
(TDF) and entecavir hydrate (ETV) in nucleos (t) ide analog (NA)‐naïve Japanese chronic …
(TDF) and entecavir hydrate (ETV) in nucleos (t) ide analog (NA)‐naïve Japanese chronic …